JP2013545455A5 - - Google Patents

Download PDF

Info

Publication number
JP2013545455A5
JP2013545455A5 JP2013537138A JP2013537138A JP2013545455A5 JP 2013545455 A5 JP2013545455 A5 JP 2013545455A5 JP 2013537138 A JP2013537138 A JP 2013537138A JP 2013537138 A JP2013537138 A JP 2013537138A JP 2013545455 A5 JP2013545455 A5 JP 2013545455A5
Authority
JP
Japan
Prior art keywords
sequence
seq
amino acid
antibody
light chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013537138A
Other languages
English (en)
Japanese (ja)
Other versions
JP5857060B2 (ja
JP2013545455A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/069369 external-priority patent/WO2012059561A1/en
Publication of JP2013545455A publication Critical patent/JP2013545455A/ja
Publication of JP2013545455A5 publication Critical patent/JP2013545455A5/ja
Application granted granted Critical
Publication of JP5857060B2 publication Critical patent/JP5857060B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013537138A 2010-11-03 2011-11-03 抗ｃ−Ｍｅｔ抗体 Active JP5857060B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40986610P 2010-11-03 2010-11-03
US61/409,866 2010-11-03
PCT/EP2011/069369 WO2012059561A1 (en) 2010-11-03 2011-11-03 Anti c-met antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015177202A Division JP2016034957A (ja) 2010-11-03 2015-09-09 抗ｃ−Ｍｅｔ抗体

Publications (3)

Publication Number Publication Date
JP2013545455A JP2013545455A (ja) 2013-12-26
JP2013545455A5 true JP2013545455A5 (enExample) 2014-12-18
JP5857060B2 JP5857060B2 (ja) 2016-02-10

Family

ID=44906140

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013537139A Pending JP2013545738A (ja) 2010-11-03 2011-11-03 ｃ−Ｍｅｔ抗体組合せ
JP2013537138A Active JP5857060B2 (ja) 2010-11-03 2011-11-03 抗ｃ−Ｍｅｔ抗体
JP2015177202A Pending JP2016034957A (ja) 2010-11-03 2015-09-09 抗ｃ−Ｍｅｔ抗体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013537139A Pending JP2013545738A (ja) 2010-11-03 2011-11-03 ｃ−Ｍｅｔ抗体組合せ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015177202A Pending JP2016034957A (ja) 2010-11-03 2015-09-09 抗ｃ−Ｍｅｔ抗体

Country Status (12)

Country Link
US (7) US9688773B2 (enExample)
EP (3) EP2635602B1 (enExample)
JP (3) JP2013545738A (enExample)
CN (2) CN103764678A (enExample)
AU (3) AU2011325098B2 (enExample)
BR (3) BR112013010687A2 (enExample)
CA (2) CA2816745C (enExample)
DK (1) DK2635602T3 (enExample)
ES (1) ES2594493T3 (enExample)
IL (2) IL226112B (enExample)
RU (2) RU2013125457A (enExample)
WO (2) WO2012059561A1 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8444976B2 (en) 2008-07-02 2013-05-21 Argen-X B.V. Antigen binding polypeptides
EP2143441A1 (en) * 2008-07-08 2010-01-13 Pierre Fabre Medicament Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer
RU2013125457A (ru) 2010-11-03 2014-12-10 Арджен-Икс Бв Комбинация антител против с-мет
KR20130036993A (ko) * 2011-10-05 2013-04-15 삼성전자주식회사 ｃ-Ｍｅｔ의 ＳＥＭＡ 도메인 내의 에피토프에 특이적으로 결합하는 항체
EP2768857B1 (en) * 2011-10-19 2020-01-01 NovImmune SA Methods of purifying antibodies
EP2773660A2 (en) * 2011-11-03 2014-09-10 Argen-X B.V. Chimeric human-camel antigens and their use
SG11201402485UA (en) 2011-11-21 2014-06-27 Genentech Inc Purification of anti-c-met antibodies
US20150147274A1 (en) * 2011-12-02 2015-05-28 Cancer Research Technology Limited Antibodies against hgf - receptor and uses
US9670275B2 (en) 2012-01-23 2017-06-06 Ablynx N.V. Sequences directed against hepatocyte growth factor (HGF) and polypeptides comprising the same for the treatment of cancers and/or tumors
EP2708556B1 (en) * 2012-09-12 2018-11-07 Samsung Electronics Co., Ltd Pharmaceutical composition for the use in a combination therapy for prevention or treatment of c-met or angiogenesis factor induced diseases
US9168300B2 (en) 2013-03-14 2015-10-27 Oncomed Pharmaceuticals, Inc. MET-binding agents and uses thereof
US9535055B2 (en) * 2013-03-28 2017-01-03 Samsung Electronics Co., Ltd. Marker for determining effects of anti-c-Met antibody and method of determining effects of anti-c-Met antibody using the marker
EP2786765B1 (en) 2013-04-01 2018-10-03 Samsung Electronics Co., Ltd. Composition for combination therapy comprising an anti-C-met antibody and a FGFR inhibitor
KR102139607B1 (ko) * 2013-04-01 2020-07-30 삼성전자주식회사 항 c-Met 항체 및 FGFR 저해제를 포함하는 병용 투여용 약학 조성물
US10214593B2 (en) 2013-04-02 2019-02-26 Samsung Electronics Co., Ltd. Anti-idiotype antibody against anti-c-MET antibody
KR102060540B1 (ko) * 2013-04-03 2019-12-31 삼성전자주식회사 항 c-Met 항체 및 항 Ang2 항체를 포함하는 병용 투여용 약학 조성물
JP6491642B2 (ja) * 2013-04-30 2019-03-27 エージェンシー フォー サイエンス， テクノロジー アンド リサーチ ｍＡｂ２抗Ｍｅｔ抗体
KR102186363B1 (ko) * 2013-09-06 2020-12-04 삼성전자주식회사 c-Met 저해제 및 베타-카테닌 저해제를 포함하는 병용 투여용 약학 조성물
KR102192591B1 (ko) * 2013-09-09 2020-12-18 삼성전자주식회사 c-Met 저해제 및 c-Myc 저해제를 포함하는 병용 투여용 약학 조성물
US11186873B2 (en) * 2014-07-29 2021-11-30 Wellmarker Bio Co., Ltd. Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET)
WO2016042412A1 (en) * 2014-09-16 2016-03-24 Symphogen A/S Anti-met antibodies and compositions
EP3270918A4 (en) 2015-03-16 2018-10-24 Celldex Therapeutics, Inc. Anti-met antibodies and methods of use thereof
GB201611123D0 (en) * 2016-06-27 2016-08-10 Euremab Srl Anti met antibodiesand uses thereof
JP7274413B2 (ja) 2016-09-23 2023-05-16 マレンゴ・セラピューティクス，インコーポレーテッド ラムダ及びカッパ軽鎖を含む多重特異性抗体分子
TWI782930B (zh) 2016-11-16 2022-11-11 美商再生元醫藥公司 抗ｍｅｔ抗體，結合ｍｅｔ之雙特異性抗原結合分子及其使用方法
WO2018221969A1 (en) * 2017-05-30 2018-12-06 Chong Kun Dang Pharmaceutical Corp. A novel anti-c-met antibody and use thereof
CA3061704C (en) * 2017-05-30 2024-01-23 Chong Kun Dang Pharmaceutical Corp. Anti-c-met antibody and use thereof
AU2018304173A1 (en) 2017-07-17 2020-01-30 Janssen Biotech, Inc. Antigen binding regions against fibronectin type III domains and methods of using the same
CN109771642B (zh) 2017-11-13 2022-09-20 同济大学苏州研究院 c-MET激动型抗体及其用途
US11591390B2 (en) 2018-09-27 2023-02-28 Celgene Corporation SIRP-α binding proteins and methods of use thereof
KR20210086619A (ko) * 2018-09-27 2021-07-08 셀진 코포레이션 SIRPα 결합 단백질 및 이의 사용 방법
MX2022002886A (es) 2019-09-16 2022-04-06 Regeneron Pharma Proteinas de union met radiomarcadas para la obtencion de imagenes por inmuno-pet.
CN117157325A (zh) 2021-04-08 2023-12-01 拜奥迪斯私人有限公司 抗c-met抗体和抗体-药物缀合物
AU2022339667A1 (en) * 2021-09-03 2024-04-11 Go Therapeutics, Inc. Anti-glyco-cmet antibodies and their uses
AU2024277829A1 (en) 2023-05-19 2025-12-04 Les Laboratoires Servier Anti-met antibodies, antibody-drug conjugates, compositions and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5892019A (en) 1987-07-15 1999-04-06 The United States Of America, As Represented By The Department Of Health And Human Services Production of a single-gene-encoded immunoglobulin
US5648273A (en) 1989-12-27 1997-07-15 The United States Of America, As Represented By The Department Of Health And Human Services Hepatic growth factor receptor is the MET proto-oncogene
EP0662130B1 (en) 1992-09-18 1997-11-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES A method of producing hepatocyte growth factor and a cell line
US6214344B1 (en) 1995-06-02 2001-04-10 Genetech, Inc. Hepatocyte growth factor receptor antagonists and uses thereof
US5686292A (en) 1995-06-02 1997-11-11 Genentech, Inc. Hepatocyte growth factor receptor antagonist antibodies and uses thereof
EP0922102B1 (en) 1996-07-03 2010-04-21 Genentech, Inc. Hepatocyte growth factor receptor agonists and uses thereof
ITMI20031127A1 (it) 2003-06-05 2004-12-06 Uni Degli Studi Del Piemont E Orientale Am Anticorpi anti-hgf-r e loro uso
CN101614745A (zh) * 2003-06-06 2009-12-30 健泰科生物技术公司 调节HGFβ链和C-MET的相互作用
HN2004000285A (es) 2003-08-04 2006-04-27 Pfizer Prod Inc ANTICUERPOS DIRIGIDOS A c-MET
KR100556660B1 (ko) * 2003-11-11 2006-03-10 국립암센터 Ｈｇｆ의 중화가능 에피토프 및 이에 결합하는 중화 항체
CA2548282A1 (en) 2003-12-11 2005-06-30 Genentech, Inc. Methods and compositions for inhibiting c-met dimerization and activation
AU2005267720B2 (en) * 2004-08-05 2012-02-23 Genentech, Inc. Humanized anti-cmet antagonists
CN101360511A (zh) 2005-11-16 2009-02-04 法里巴·内耶里 用内源c-met配体和抑制剂抑制个体中的癌发生和/或转移的方法
US8388958B2 (en) 2006-02-06 2013-03-05 Metheresis Translational Research Sa Anti-MET monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products
MX2008012485A (es) * 2006-03-30 2008-10-10 Novartis Ag Composiciones y metodos de uso para anticuerpos de c-met.
FR2906533B1 (fr) 2006-09-28 2013-02-22 Pf Medicament Procede de generation d'anticorps actifs contre un antigene de resistance,anticorps obtenus par ledit procede et leurs utilisations
EP2014681A1 (en) 2007-07-12 2009-01-14 Pierre Fabre Medicament Novel antibodies inhibiting c-met dimerization, and uses thereof
EP2177623A4 (en) 2007-07-19 2010-12-29 Eisai R&D Man Co Ltd SCREENING METHOD USING C-MET, A NEW SUBSTRATE FOR GAMMA SECRETASE
US7892770B2 (en) 2007-08-24 2011-02-22 Van Andel Research Institute Monoclonal antibody which binds cMet (HGFR) in formalin-fixed and paraffin-embedded tissues and related methods
IL198545A0 (en) 2008-05-14 2011-07-31 Metheresis Translational Res Sa High affinity binding site of hgfr and methods for identification of antagonists thereof
WO2009142738A2 (en) 2008-05-21 2009-11-26 Oncomed Pharmaceuticals, Inc. Compositions and methods for diagnosing and treating cancer
CA2725919A1 (en) 2008-05-28 2009-12-03 Roland Antonius Paulus Romijn Method for the production of proteins or protein fragments
GB2461546B (en) 2008-07-02 2010-07-07 Argen X Bv Antigen binding polypeptides
WO2010005965A1 (en) 2008-07-08 2010-01-14 Aronchick Craig A Colonic purgative formulations and methods of using the same
PA8849001A1 (es) 2008-11-21 2010-06-28 Lilly Co Eli Anticuerpos de c-met
AR074439A1 (es) 2008-12-02 2011-01-19 Pf Medicament Anticuerpo anti-cmet (receptor c-met)
US8545839B2 (en) 2008-12-02 2013-10-01 Pierre Fabre Medicament Anti-c-Met antibody
RU2013125457A (ru) 2010-11-03 2014-12-10 Арджен-Икс Бв Комбинация антител против с-мет

Similar Documents

Publication Publication Date Title
JP2013545455A5 (enExample)
RU2013125459A (ru) АНТИТЕЛА ПРОТИВ БЕЛКА РЕЦЕПТОРА c-Met
JP2020525032A5 (enExample)
JP2016512551A5 (enExample)
JP2020508655A5 (enExample)
JP2013545738A5 (enExample)
JP2010533498A5 (enExample)
JP2018527919A5 (enExample)
JP2017504578A5 (enExample)
RU2018142544A (ru) Биспецифические связывающие белки и пути их применения
HRP20180147T1 (hr) Cea protutijela
JP2012501669A5 (enExample)
JP2018510636A5 (enExample)
JP2019524693A5 (enExample)
JP2018507188A5 (enExample)
JP2020533311A5 (ja) ＮＫＧ２Ｄ、ＣＤ１６およびＮｅｃｔｉｎ４に結合するタンパク質
SI2686347T1 (en) Antibodies against CD70
JP2014039548A5 (enExample)
JP2013502913A5 (enExample)
RU2016100892A (ru) Антитела против tweakr и их применение
JP2013519364A5 (enExample)
JP2017520575A5 (enExample)
JP2018510617A5 (enExample)
JP2012530496A5 (enExample)
JP2013520984A5 (enExample)